Показано 0 из 0
Дата |
---|
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
19.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
39.00
|
38.40
|
39.00
|
38.75
|
|
|
758 820.79
|
|
|
|
39.00
|
38.90
|
39.50
|
39.50
|
|
|
441 623.60
|
|
|
|
39.75
|
38.20
|
40.00
|
39.05
|
|
|
1 048 307.66
|
|
|
|
39.90
|
39.45
|
39.90
|
39.75
|
|
|
427 010.55
|
|
|
|
40.90
|
39.60
|
41.10
|
39.90
|
|
|
846 956.80
|
|
|
|
40.80
|
40.60
|
40.90
|
40.90
|
|
|
351 142.30
|
|
|
|
40.50
|
40.50
|
41.00
|
40.80
|
|
|
701 797.10
|
|
|
|
40.20
|
40.20
|
40.75
|
40.55
|
|
|
934 249.55
|
|
|
|
41.00
|
40.60
|
41.10
|
40.60
|
|
|
388 803.80
|
|
|
|
41.60
|
40.80
|
41.60
|
40.80
|
|
|
887 715.28
|
|
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through its fully integrated research and development operations the company focuses on the development of innovative antibiotics, antifungals and oncology drugs, targeting the medical challenge of resistance and non-response to current treatment options.